Finnish Institute For Health And Welfare

3 trials 1 recruiting Academic / non-commercial

Filter these 3 trials by condition, phase, country and more.

Open in Search →
3 Registered trials
1 Recruiting
2 Completed trials
1 Countries active
17 Unique IMPs
100% Results reported
Phase IV: 3
100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Bacterial infection 1 Influenza immunisation 1 Influenza 1 COVID-19 1

Top IMPs

5'-CAPPED MRNA ENCODING SARS-COV-2, VARIANT LP.8.1, SPIKE PROTEIN, PRE-FUSION STABILISED (K981P AND V982P) 1 A/TURKEY/TURKEY/1/05 (H5N1)-LIKE STRAIN (NIBRG-23) 1 B/PHUKET/3073/2013-LIKE STRAIN (B/PHUKET/3073/2013, BVR-1B), INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26), INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED, INFLUENZA VIRUS A/THAILAND/8/2022 (H3N2) IVR-237-LIKE STRAIN (A/THAILAND/8/2022) 1 B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2), INFLUENZA VIRUS B/MICHIGAN/01/2021, INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED 1 BRETOVAMERAN 1 ELASOMERAN 1 ELASOMERAN, IMELASOMERAN 1 INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8)-LIKE STRAIN (CBER-RG8A) (CLADE 2.3.4.4B) 1 INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26), INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED, INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED 1 INFLUENZA VIRUS B/MICHIGAN/01/2021, INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED, INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED 1 RAXTOZINAMERAN 1 SARS-COV-2 VIRUS, VARIANT LP.8.1, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HOMODIMER 1

All trials

3 total

Showing 1–3 of 3 trials

← All sponsors A–Z